Clinical Trial Update: Evaluation of Immune Response Against the Strain of Neisseria Meningitidis B: 14, P1-7, 16 Patients Vaccinated With MenBVac® (Extension MenbVac) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating immune response to MenBVac vaccination against Neisseria meningitidis B:14 (extension study; 16 vaccinated participants…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menb Disease
• Neisseria Meningitidis Infection

Drugs mentioned

• MenBVac (Meningococcal B vaccine)

Snippet

Sponsor: University Hospital, Rouen | Conditions: Vaccination With MenbVac | Phase 3 | Status: COMPLETED